Increased neurofilament light chain blood levels in neurodegenerative neurological diseases. - Wikidata - wikimedia - TriplyDB

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

http://www.wikidata.org/entity/Q35000781

about

Role of Intermediate Filaments in Vesicular Traffic Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.Blood biomarkers for amyotrophic lateral sclerosis: myth or reality?Neuronal Damage Induced by Perinatal Asphyxia Is Attenuated by Postinjury Glutaredoxin-2 Administration Diffuse axonal injury in brain trauma: insights from alterations in neurofilaments.Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis Comparative Assessment of the Prognostic Value of Biomarkers in Traumatic Brain Injury Reveals an Independent Role for Serum Levels of Neurofilament Light Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.CSF neurofilament light chain reflects corticospinal tract degeneration in ALS.Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.An indicator cell assay for blood-based diagnostics.ALS biomarkers for therapy development: State of the field and future directions.Plasma neurofilament light chain predicts progression in progressive supranuclear palsy Post-infectious inflammatory response syndrome (PIIRS): Dissociation of T-cell-macrophage signaling in previously healthy individuals with cryptococcal fungal meningoencephalitis.Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children.Neurofilament light chain: a biomarker for genetic frontotemporal dementia Motor neuron disease in 2014. Biomarkers for ALS--in search of the Promised Land Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder Urinary p75ECD: A prognostic, disease progression, and pharmacodynamic biomarker in ALS.ADSC therapy in neurodegenerative disorders.Neurofilament dynamics and involvement in neurological disorders.Neuroproteomic profiling of human body fluids.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosis.Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.The cerebrospinal fluid in multiple sclerosis: far beyond the bands.Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases.Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration.Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome.The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood.Neurofilaments in CSF As Diagnostic Biomarkers in Motor Neuron Disease: A Meta-Analysis.Neurofilaments and Neurofilament Proteins in Health and Disease.Biomarkers in Neurodegenerative Diseases.Effect of carotid endarterectomy on brain damage markers.A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.

P2860

Q26749357-2C9CACC4-66D1-4FCD-9CEA-E28DA5AB072F Q26774743-934EBF27-CC7D-4769-9AD9-09BD113006AB Q26785669-D6C0B1C8-DAFE-469A-BAF6-1AC633186672 Q26823418-DFAA2BA1-9DE9-4DDE-945A-AA9DAA6879C0 Q30224292-A93E4C28-8B5B-4893-B9FC-F03F1D43B0D8 Q31141202-0E66FDD0-1E77-4151-8E52-EED04E62C915 Q33767845-E5C5AB2F-E9F0-498E-927E-F68B61123001 Q33863777-94DB23A5-EF0C-4120-804B-491040B9BBD7 Q34722271-AFC3C568-0D79-4911-87CF-AD744AAF5E66 Q35537489-A009F08E-C0F9-48E6-9E6C-974DDE777B28 Q35645083-184F7DCD-D2F7-49DC-A648-104AD2B11717 Q35681358-C8D139E0-0845-44F5-BDB8-E0764B923C29 Q35686186-4AA85C15-E3C0-45A5-8313-E6CC2B657E1B Q35935100-675E59B7-D13F-4A81-85ED-A029F7AE0968 Q36161527-0ED791B3-4202-4C5C-90C5-1A367170C543 Q36395874-5330F3BA-EF04-4CA1-A2B1-FC931909CA2E Q36479616-4E76F820-E1EC-4ED6-913E-A4D65F7A788D Q36639639-EC7F8B32-A797-491D-B812-EFF38DA85BE4 Q36781260-E88DF218-1C40-4395-8773-593EF69CC604 Q37205326-7CC77076-9A6A-4F11-BD3A-0FF6D1D16E92 Q37208495-DFD69D3C-CDD7-47B9-A2A1-5EB2502F2ADF Q37532592-0AB8EBAC-4BC9-4ADE-90E9-9627F0F28262 Q37676938-98DB5F44-BEF6-4967-B4FB-9A89EDD1814C Q37730505-DFE361D7-731F-41FB-9D8A-D9766427EE03 Q38210872-1DD56A4C-934A-4CAF-8D5E-DF633FC4F7C6 Q38310624-A0F583CA-88A4-42B9-B074-012CED8A2686 Q38569255-5B95CA0E-C979-4FE3-AA17-D53C2740AC2B Q38590773-D050B86A-41A6-4526-8DA2-869169FCC218 Q38643847-5DBCC868-56D0-4C32-B03D-3489A88E0366 Q38682945-F764A69A-ACEF-4153-9467-5F44CECF4AF2 Q38819421-E4F06D71-C84B-43F9-B4B3-502765CEB81C Q38984981-A5208374-C7AA-4355-82AE-74A453D74476 Q39030144-7C713F99-F3EB-43CF-98F1-23D7817BA901 Q39035274-CB3F7306-6D11-44DC-96EF-640A7D2BAABE Q39044367-99825245-29AC-4C6C-9DAF-B322664B7223 Q39103639-9BF3EEE1-5CE5-427C-A705-7A6402D8D713 Q39217671-23D0DD72-07E1-46C8-BE94-BDE2001A7BFE Q39413097-A56A91E3-E28D-4E36-9D0F-E1768AB23B02 Q39811657-F45B0AD2-F943-4746-B3E8-B2FB5DC25D82 Q41369774-95504333-ABAF-440B-9D9F-4791082DDBB2

P2860

Increased neurofilament light chain blood levels in neurodegenerative neurological diseases.

http://www.wikidata.org/entity/Q35000781

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Increased neurofilament light ...... erative neurological diseases.

@ast

Increased neurofilament light ...... erative neurological diseases.

@en

type

label

Increased neurofilament light ...... erative neurological diseases.

@ast

Increased neurofilament light ...... erative neurological diseases.

@en

prefLabel

Increased neurofilament light ...... erative neurological diseases.

@ast

Increased neurofilament light ...... erative neurological diseases.

@en

P1433

Q35000781-EECFE3E0-7196-4249-8ED7-94731F2C739E

P1476

Q35000781-43862988-CF71-414C-88DF-943C8E0EC5B7

P2093

Q35000781-18218DEC-F94A-4A25-9813-26A97E7FA8E5

Q35000781-2C518FCB-1A3C-4FC2-B877-B06AEE95AF35

Q35000781-2DA0AE90-33D9-41A0-830B-B33C7581F2CF

Q35000781-3FDCE584-7E55-4C0E-A153-B6EA18DA2625

Q35000781-54773355-A93B-465A-BE46-A5A05E07A768

Q35000781-84B3003A-3F44-42FB-BFFE-CD973D389119

Q35000781-876A4621-F994-466D-9F73-30FDFD530E4A

Q35000781-B10B80D6-8D91-416D-AC00-536646CE1C61

Q35000781-BEF948CF-AA26-46D7-9B10-BA941BA653B9

Q35000781-C803BA17-BA80-434D-9BE6-2B679C793AC6

P2860

Q35000781-03344A7E-EBDA-449E-A466-22C168E95EEF

Q35000781-05C7C91B-390D-4987-ACE9-909B4959EFE6

Q35000781-09A0B145-D9BC-4850-BA5C-D8A981C1CDEE

Q35000781-0EA83C2D-3796-46D4-8C97-D303AFBD7224

Q35000781-1892AD9C-FA6F-42F5-8AAB-CF3DCF7BD9B0

Q35000781-20D692F2-EEFE-4656-A59B-2E184368E268

Q35000781-27800D99-AB53-4406-9C5F-B15CD796F1F3

Q35000781-31A2C4EC-9F6D-4567-BB06-CA026BB374AC

Q35000781-37592860-D06D-4B5F-940A-6D17F626D0D0

Q35000781-3ABD2B73-8588-48D9-8572-7175668AF862

P304

Q35000781-15E78E36-E70E-4C51-B237-1C26DCAE2C90

P31

Q35000781-14FDC498-026F-44B0-A3AC-2FA790975BC6

P356

Q35000781-665343CD-14D6-4ADE-8392-F85F2041BE9A

P407

Q35000781-A73F5FE5-52A5-4C8C-88FC-28089961F97D

P433

Q35000781-2F58169C-C4DE-45D9-9053-0D52C9054556

P478

Q35000781-EAE56462-1111-497D-9A3C-420959660A9E

P50

Q35000781-374D782C-4190-41C6-9F6A-EABD75338AA9

Q35000781-39B08FC3-A8CB-4EEF-835A-9CF145545860

Q35000781-FCF5655B-FFCF-4B32-A6F1-5F79A94B9D97

P577

Q35000781-3FDB00CF-E5C9-4CBA-8DA6-C69B04D94479

P5875

Q35000781-A6C15586-8A04-43A4-805E-95A4FC456CAB

P698

Q35000781-5E5FEBC6-8634-47D3-8370-EFC824F855CB

P921

Q35000781-EB26FDC6-9C30-45D9-B2EE-CD14613B291F

P932

Q35000781-A29F7463-7AF7-4928-811C-CA71146BD776

P356

JOURNAL.PONE.0075091

P1433

P1476

Increased neurofilament light ...... erative neurological diseases.

@en

P2093

Ahuva Nissim

http://www.w3.org/2001/XMLSchema#string

Andrea Malaspina

http://www.w3.org/2001/XMLSchema#string

Andreas U Monsch

http://www.w3.org/2001/XMLSchema#string

Axel Regeniter

http://www.w3.org/2001/XMLSchema#string

David Leppert

http://www.w3.org/2001/XMLSchema#string

Jens Kuhle

http://www.w3.org/2001/XMLSchema#string

Joanne Topping

http://www.w3.org/2001/XMLSchema#string

Johanna Gaiottino

http://www.w3.org/2001/XMLSchema#string

Jonathan P Bestwick

http://www.w3.org/2001/XMLSchema#string

Niklas Norgren

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF.

Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.

Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS.

Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.

Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker.

Axonal degeneration and inflammation in acute optic neuritis.

Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss.

The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.

P304

e75091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0075091

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Gavin Giovannoni

P577

2013-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257136598

http://www.w3.org/2001/XMLSchema#string

P698

24073237

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

3779219

http://www.w3.org/2001/XMLSchema#string